Qaddoumi et al. recently identified BRAF mutations in 53% of ganglioglioma, with V600E mutations accounting for 35% of cases, and FGFR1 mutations in 82% of DNETs [13]. This evidence concerns the gene FGFR1 and ganglioglioma.